Jay Stoudemire
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- Advanced biosensing and bioanalysis techniques
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- RNA Interference and Gene Delivery 4
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 3
- Circular RNAs in diseases 3
-
- MicroRNA in disease regulation 8
- Co-authors
- Andreas G. Bader (8 shared papers)Mitesh J. Borad (6 shared papers)Andrew Brenner (5 shared papers)Jasgit C. Sachdev (6 shared papers)David S. Hong (5 shared papers)Sinil Kim (5 shared papers)Yoon‐Koo Kang (3 shared papers)Muhammad S. Beg (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (2 papers)Cancer Research (2 papers)Investigational New Drugs (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Jay Stoudemire
14 papers receiving 1.1k citations
Jay Stoudemire's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 751
- Molecular Biology 841
- Immunology 73
- Biomaterials 41
- Oncology 75
Countries citing papers authored by Jay Stoudemire
This map shows the geographic impact of Jay Stoudemire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Stoudemire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Stoudemire more than expected).
Fields of papers citing papers by Jay Stoudemire
This network shows the impact of papers produced by Jay Stoudemire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Stoudemire. The network helps show where Jay Stoudemire may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Stoudemire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors Hit paper breakdown → | 2016 | 700 |
| 2 | 2011 | 256 | |
| 3 | 2014 | 57 | |
| 4 | 2016 | 29 | |
| 5 | 2014 | 19 | |
| 6 | 2015 | 18 | |
| 7 | 2016 | 9 | |
| 8 | 2014 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 3 | |
| 11 | A novel pan inhibitor of Bcl-2 and Mcl-1 apogossypolone (ApoG2) with superior stability and improved activity against human leukemia and lymphoma cells. | 2007 | 3 |
| 12 | 2021 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2012 | 1 |
About Jay Stoudemire
Jay Stoudemire is a scholar working on Molecular Biology, Cancer Research, Public Health, Environmental and Occupational Health, Hematology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (5 papers), RNA Interference and Gene Delivery (4 papers), Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Protein Degradation and Inhibitors (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (751 citations), Molecular Biology (841 citations), Immunology (73 citations), Biomaterials (41 citations) and Oncology (75 citations). Jay Stoudemire has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Andreas G. Bader, Mitesh J. Borad, Andrew Brenner, Jasgit C. Sachdev, David S. Hong, Sinil Kim, Yoon‐Koo Kang, Muhammad S. Beg, David T. Brown and Paul Lammers. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Investigational New Drugs and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.